Zydus and TLC sign agreement to market Liposomal Amphotericin B in India
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
The turnover of its NPNC Formulations Division (IKKT Undertaking) for FY 2020-2021 is Rs.21.33 Cr
The company plans to enter the EU markets in FY22
This marks Glenmark's first synthetic decapeptide injectable approval
It posted net profit of Rs.188.77 crores for the period ended March 31, 2020.
NATCO and Arrow shall launch the product on agreed-upon launch dates in the future.
First batch produced at Panacea Biotec’s facilities at Baddi will be shipped to the Gamaleya Center for quality control and full scale production of the vaccine is due to start this summer
Allecra Therapeutics would now either directly or through out license file for NDA of this molecule.
Availability of drugs is being monitored by implementing a three-pronged strategy of supply chain management, demand side management, and affordability.
This kit was developed in partnership with Gujarat-based LabCare Diagnostics. LabCare is into clinical chemistry reagents, serology tests, immuno-chromatographic tests and urine analysis strips
Subscribe To Our Newsletter & Stay Updated